Absence of the adaptor protein Shb potentiates the T helper type 2 response in a mouse model of atopic dermatitis

Immunology

Volumn 143, Issue 1, 2014, Pages 33-41

  Gustafsson, Karin ^a   Willebrand, Elsa ^a   Welsh, Michael ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Atopic dermatitis; Cytokines; Src homology domain protein B; T helper type 2 responses; T cell receptor signalling

Indexed keywords

ADAPTOR PROTEIN; CALCIPOTRIOL; CYTOKINE; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; RNA; SRC HOMOLOGY DOMAIN PROTEIN B; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE MODEL; EAR; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EPIDERMIS HYPERPLASIA; FEMALE; HELPER CELL; HISTOLOGY; IMMUNE SYSTEM; IMMUNOREGULATION; INFLAMMATION; KNOCKOUT MOUSE; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MAST CELL; MEDIATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SRC HOMOLOGY DOMAIN; SYMPTOM; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ATOPIC DERMATITIS; CYTOKINES; SRC HOMOLOGY DOMAIN PROTEIN B; T HELPER TYPE 2 RESPONSES; T-CELL RECEPTOR SIGNALLING;

ANIMALS; CELL DIFFERENTIATION; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 84904901214     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12286     Document Type: Article

References (80)

1. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-32.
2. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-57.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-64.
4. McKenzie AN, Culpepper JA, de Waal Malefyt R et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90:3735-9.
5. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989; 245:308-10.
6. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993; 362:245-8.
7. Else KJ, Finkelman FD, Maliszewski CR, Grencis RK. Cytokine-mediated regulation of chronic intestinal helminth infection. J Exp Med 1994; 179:347-51.
8. Hirota K, Yoshitomi H, Hashimoto M et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 2007; 204:2803-12.
9. Robinson DS, Hamid Q, Ying S et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
10. Annunziato F, Cosmi L, Santarlasci V et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204:1849-61.
11. Macfarlane AJ, Kon OM, Smith SJ et al. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol 2000; 105:99-107.
12. Reilly KM, Yap PL, Dawes J, Barnetson RS, MacKenzie F, Allan TL. Circulating basophil counts in atopic individuals. Int Arch Allergy Appl Immunol 1987; 84:424-6.
13. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033-9.
14. Mudde GC, van Reijsen FC, Bruijnzeel-Koomen CA. IgE-positive Langerhans cells and Th2 allergen-specific T cells in atopic dermatitis. J Invest Dermatol 1992; 99:103S.
15. Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencie PY, Gleich GJ. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med 1985; 313:282-5.
16. + T cells by antigenic peptides altered for TCR binding. J Immunol 1997; 158:4237-44.
17. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J Exp Med 1995; 182:1579-84.
18. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 1993; 90:10188-92.
19. + T cells from T cell receptor transgenic mice. J Exp Med 1992; 176:1091-8.
20. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995; 181:1569-74.
21. + T cells into the Th2 subset. J Immunol 2001; 167:1962-9.
22. Yamashita M, Kimura M, Kubo M, Shimizu C, Tada T, Perlmutter RM, Nakayama T. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc Natl Acad Sci USA 1999; 96:1024-9.
23. Blonska M, Joo D, Zweidler-McKay PA, Zhao Q, Lin X. CARMA1 controls Th2 cell-specific cytokine expression through regulating JunB and GATA3 transcription factors. J Immunol 2012; 188:3160-8.
24. Mingueneau M, Roncagalli R, Gregoire C et al. Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor. Immunity 2009; 31:197-208.
25. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N Engl J Med 1997; 337:1720-5.
26. Tamura K, Arakawa H, Suzuki M, Kobayashi Y, Mochizuki H, Kato M, Tokuyama K. Novel dinucleotide repeat polymorphism in the first exon of the STAT-6 gene is associated with allergic diseases. Clin Exp Allergy 2001; 31:1509-14.
27. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183:195-201.
28. Walter DM, McIntire JJ, Berry G, McKenzie AN, Donaldson DD, DeKruyff RH, Umetsu DT. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 2001; 167:4668-75.
29. Herrick CA, Xu L, McKenzie AN, Tigelaar RE, Bottomly K. IL-13 is necessary, not simply sufficient, for epicutaneously induced Th2 responses to soluble protein antigen. J Immunol 2003; 170:2488-95.
30. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999; 103:1103-11.
31. Brusselle G, Kips J, Joos G, Bluethmann H, Pauwels R. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am J Respir Cell Mol Biol 1995; 12:254-9.
32. Harada M, Hirota T, Jodo AI et al. Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma. Am J Respir Cell Mol Biol 2011; 44:787-93.
33. Hunninghake GM, Soto-Quiros ME, Avila L et al. TSLP polymorphisms are associated with asthma in a sex-specific fashion. Allergy 2010; 65:1566-75.
34. Ying S, O'Connor B, Ratoff J et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005; 174:8183-90.
35. Siracusa MC, Saenz SA, Hill DA et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 2011; 477:229-33.
36. He R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, Geha RS. TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proc Natl Acad Sci USA 2008; 105:11875-80.
37. Soumelis V, Reche PA, Kanzler H et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3:673-80.
38. Allakhverdi Z, Comeau MR, Jessup HK et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204:253-8.
39. Kouzaki H, O'Grady SM, Lawrence CB, Kita H. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol 2009; 183:1427-34.
40. Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci USA 2006; 103:11736-41.
41. Knosp CA, Carroll HP, Elliott J et al. SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses. J Exp Med 2011; 208:1523-31.
42. Holmqvist K, Cross MJ, Rolny C, Hagerkvist R, Rahimi N, Matsumoto T, Claesson-Welsh L, Welsh M. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J Biol Chem 2004; 279:22267-75.
43. Hooshmand-Rad R, Lu L, Heldin CH, Claesson-Welsh L, Welsh M. Platelet-derived growth factor-mediated signaling through the Shb adaptor protein: effects on cytoskeletal organization. Exp Cell Res 2000; 257:245-54.
44. Welsh M, Songyang Z, Frantz JD et al. Stimulation through the T cell receptor leads to interactions between SHB and several signaling proteins. Oncogene 1998; 16:891-901.
45. Karlsson T, Songyang Z, Landgren E et al. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins. Oncogene 1995; 10:1475-83.
46. Lindholm CK, Henriksson ML, Hallberg B, Welsh M. Shb links SLP-76 and Vav with the CD3 complex in Jurkat T cells. Eur J Biochem 2002; 269:3279-88.
47. Lindholm CK, Gylfe E, Zhang W, Samelson LE, Welsh M. Requirement of the Src homology 2 domain protein Shb for T cell receptor-dependent activation of the interleukin-2 gene nuclear factor for activation of T cells element in Jurkat T cells. J Biol Chem 1999; 274:28050-7.
48. Kriz V, Mares J, Wentzel P et al. Shb null allele is inherited with a transmission ratio distortion and causes reduced viability in utero. Dev Dyn 2007; 236:2485-92.
49. + T cells. BMC Immunol 2011; 12:3.
50. Miles AA, Miles EM. Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs. J Physiol 1952; 118:228-57.
51. Galaup A, Cazes A, Le Jan S et al. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci USA 2006; 103:18721-6.
52. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998; 101:1614-22.
53. Dahten A, Koch C, Ernst D, Schnoller C, Hartmann S, Worm M. Systemic PPARγ ligation inhibits allergic immune response in the skin. J Invest Dermatol 2008; 128:2211-8.
54. Dialynas DP, Quan ZS, Wall KA, Pierres A, Quintans J, Loken MR, Pierres M, Fitch FW. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 1983; 131:2445-51.
55. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981; 11:805-15.
56. Hershko AY, Charles N, Olivera A, Alvarez-Errico D, Rivera J. Cutting edge: persistence of increased mast cell numbers in tissues links dermatitis to enhanced airway disease in a mouse model of atopy. J Immunol 2012; 188:531-5.
57. Grewe M, Walther S, Gyufko K, Czech W, Schopf E, Krutmann J. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995; 105:407-10.
58. H2 effector cells to cause allergy. J Allergy Clin Immunol 2011; 127:1277-85 e5.
59. Christoffersson G, Zang G, Zhuang ZW, Vagesjo E, Simons M, Phillipson M, Welsh M. Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency. Angiogenesis 2012; 15:469-80.
60. Funa NS, Kriz V, Zang G et al. Dysfunctional microvasculature as a consequence of shb gene inactivation causes impaired tumor growth. Cancer Res 2009; 69:2141-8.
61. Zang G, Christoffersson G, Tian G et al. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-α in Shb-deficient lung endothelial cells. Cell Signal 2013; 25:85-92.
62. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schroder JM. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998; 160:60-8.
63. Mathew A, MacLean JA, DeHaan E, Tager AM, Green FH, Luster AD. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med 2001; 193:1087-96.
64. Xiao T, Fujita H, Saeki H et al. Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-α and IL-4 and downregulated by IFN-γ. Cytokine 2003; 23:126-32.
65. Bonecchi R, Sozzani S, Stine JT, Luini W, D'Amico G, Allavena P, Chantry D, Mantovani A. Divergent effects of interleukin-4 and interferon-γ on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 1998; 92:2668-71.
66. Mould AW, Matthaei KI, Young IG, Foster PS. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 1997; 99:1064-71.
67. Hickey MJ, Granger DN, Kubes P. Molecular mechanisms underlying IL-4-induced leukocyte recruitment in vivo: a critical role for the α4 integrin. J Immunol 1999; 163:3441-8.
68. Burd PR, Thompson WC, Max EE, Mills FC. Activated mast cells produce interleukin 13. J Exp Med 1995; 181:1373-80.
69. Cui P, Sharmin S, Okumura Y, Yamada H, Yano M, Mizuno D, Kido H. Endothelin-1 peptides and IL-5 synergistically increase the expression of IL-13 in eosinophils. Biochem Biophys Res Commun 2004; 315:782-7.
70. Walsh ER, Thakar J, Stokes K, Huang F, Albert R, August A. Computational and experimental analysis reveals a requirement for eosinophil-derived IL-13 for the development of allergic airway responses in C57BL/6 mice. J Immunol 2011; 186:2936-49.
71. Gessner A, Mohrs K, Mohrs M. Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol 2005; 174:1063-72.
72. + memory T cells from the spleen lack MEL-14, the lymph node homing receptor. J Immunol 1992; 148:324-31.
73. Budd RC, Cerottini JC, Horvath C, Bron C, Pedrazzini T, Howe RC et al. Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol 1987; 138:3120-9.
74. + T cells toward distinct T-helper cell subsets. Immunol Rev 2013; 252:12-23.
75. + T cells. J Immunol 1995; 154:4915-23.
76. + T cells to generate a Th2-inducing cytokine environment. J Exp Med 2005; 202:793-804.
77. + T cells. J Immunol 2003; 170:2427-34.
78. + T cells. J Immunol 2002; 168:3825-32.
79. Jun JE, Wilson LE, Vinuesa CG et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 2003; 18:751-62.
80. Siggs OM, Miosge LA, Yates AL et al. Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 2007; 27:912-26.